Q1 2022 Holdings
Filed 2022-05-13 | 54 holdings | $206.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ALX Oncology Holdings Inc(ALXO) | Common | 00166B105 | $71.3M | 4,220,048 | 34.6% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $51.9M | 442,502 | 25.2% |
| Celldex Therapeutics Inc(CLDX) | Common | 15117B202 | $21.4M | 628,356 | 10.4% |
| Aclaris Therapeutics, Inc.(ACRS) | Common | 00461U105 | $15.5M | 898,631 | 7.5% |
| Cogent Biosciences Inc(COGT) | Common | 19240Q201 | $14.4M | 1,920,941 | 7.0% |
| Aadi Bioscience Inc(WHWK) | Common | 00032Q104 | $13.1M | 772,416 | 6.4% |
| Codexis, Inc(CDXS) | Common | 192005106 | $8.0M | 388,144 | 3.9% |
| Arrowhead Pharmaceuticals Inc(ARWR) | Common | 04280A100 | $6.3M | 137,411 | 3.1% |
| Compass Therapeutics Inc(CMPX) | Common | 20454B104 | $2.7M | 2,000,000 | 1.3% |
| Harmony Biosciences Holdings Inc(HRMY) | Common | 413197104 | $222.3K | 4,570,148 | 0.1% |
| New Frontier Health Corp | Ord Shs | G6461G106 | $170.9K | 14,300,000 | 0.1% |
| Instil Bio Inc | Common | 45783C101 | $134.2K | 12,486,787 | 0.1% |
| Iveric Bio Inc(OPHTEUR) | Common | 46583P102 | $108.3K | 6,431,940 | 0.1% |
| Sierra Oncology, Inc | Common | 82640U404 | $106.7K | 3,329,511 | 0.1% |
| Amyris, Inc(AMRSEUR) | Common | 03236M200 | $50.8K | 11,642,195 | 0.0% |
| Tarsus Pharmaceuticals Inc(TARS) | Common | 87650L103 | $50.2K | 2,987,331 | 0.0% |
| Sinovac Biotech Ltd.(SVA) | SHS | P8696W104 | $38.2K | 5,900,000 | 0.0% |
| Ventyx Biosciences Inc(VTYX) | Common | 92332V107 | $26.1K | 1,921,726 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | Common | 92790C104 | $24.0K | 1,300,000 | 0.0% |
| KalVista Pharmaceuticals Inc.(KALV) | Common | 483497103 | $22.6K | 1,533,559 | 0.0% |
| Geron Corp(GERN) | Common | 374163103 | $20.7K | 15,238,095 | 0.0% |
| Avadel Pharmaceuticals PLC | ADR | 05337M104 | $20.1K | 2,937,093 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | Common | 75955J402 | $19.1K | 705,882 | 0.0% |
| Impel NeuroPharma Inc | Common | 45258K109 | $18.4K | 2,884,789 | 0.0% |
| Genetron Holdings Ltd | ADS | 37186H100 | $16.2K | 7,411,577 | 0.0% |
| IO Biotech Inc(IOBT) | Common | 449778109 | $16.0K | 3,015,545 | 0.0% |
| Vera Therapeutics Inc(VERA) | Common | 92337R101 | $15.7K | 666,666 | 0.0% |
| Chinook Therapeutics Inc(290A) | Common | 16961L106 | $14.3K | 872,151 | 0.0% |
| Verona Pharma PLC(VRNA) | ADS | 925050106 | $13.7K | 2,749,918 | 0.0% |
| Merus NV | Common | N5749R100 | $11.7K | 442,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | Common | 462260100 | $10.9K | 655,057 | 0.0% |
| Bolt Therapeutics Inc(BOLT1EUR) | Common | 097702104 | $10.6K | 3,871,291 | 0.0% |
| Minerva Surgical Inc | Common | 60343F106 | $10.0K | 2,215,667 | 0.0% |
| Legend Biotech Corp Sponsored(LEGN) | SPONSORED ADS | 52490G102 | $8.9K | 244,375 | 0.0% |
| Zai Lab Ltd ADR(ZLAB) | ADR | 98887Q104 | $8.0K | 181,577 | 0.0% |
| Terns Pharmaceuticals Inc(TERN) | Common | 880881107 | $7.9K | 2,675,133 | 0.0% |
| Design Therapeutics(DSGN) | Common | 25056L103 | $7.7K | 476,589 | 0.0% |
| Aligos Therapeutics Inc | Common | 01626L105 | $7.6K | 3,547,030 | 0.0% |
| Olema Pharmaceuticals Inc(OLMA) | Common | 68062P106 | $7.2K | 1,689,515 | 0.0% |
| Sera Prognostics Inc(SERA) | Common | 81749D107 | $7.0K | 1,856,011 | 0.0% |
| Bellus Health Inc(BLU) | Common | 07987C204 | $7.0K | 1,017,152 | 0.0% |
| Nkarta Inc(NKTX) | Common | 65487U108 | $5.8K | 512,225 | 0.0% |
| Dyne Therapeutics Inc(DYN) | Common | 26818M108 | $5.6K | 577,642 | 0.0% |
| Satsuma Pharmaceuticals Inc | Common | 80405P107 | $4.7K | 1,232,394 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | ADS | 589492107 | $4.3K | 3,795,225 | 0.0% |
| Dice Therapeutics Inc | Common | 23345J104 | $3.1K | 163,136 | 0.0% |
| Homology Medicines, Inc. | Common | 438083107 | $2.6K | 853,143 | 0.0% |
| Aslan Pharmaceuticals Ltd | ADS | 04522R101 | $2.6K | 2,840,909 | 0.0% |
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | $2.2K | 961,359 | 0.0% |
| Zymeworks Inc | Common | 98985W102 | $1.9K | 286,064 | 0.0% |